Question 1

What is Garda Therapeutics?

Accepted Answer

Garda Therapeutics is a Entity.

Question 2

How often does Garda Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 55 articles.

Question 3

When was Garda Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 01, 2026.

Question 4

When was Garda Therapeutics last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Garda Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: -5 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Garda Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Garda Therapeutics?

Accepted Answer

Monteverde Investigates Multiple Mergers, Sales (Apr 01, 2026, 47 articles).

Question 8

How did the "Monteverde Investigates Multiple Mergers, Sales" event impact Garda Therapeutics?

Accepted Answer

Garda Therapeutics is the proposed acquirer of Assertio Holdings.

Question 9

How did the "Zydus Lifesciences acquires Assertio Holdings" event impact Garda Therapeutics?

Accepted Answer

Assertio Holdings' board terminated an earlier merger agreement with Garda Therapeutics to proceed with the Astec LifeSciences acquisition, deeming Zydus's offer superior.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.